Literature DB >> 10483538

Gestational diabetes. Is a 50-g screening result > or = 200 mg/dL diagnostic?

S A Shivvers1, M J Lucas.   

Abstract

OBJECTIVE: To evaluate the diagnosis of gestational diabetes based on a 50-g, one-hour glucose screening test result > or = 200 mg/dL. STUDY
DESIGN: Retrospective ascertainment of pregnant women who had a 50-g, one-hour glucose screening test result > or = 200 mg/dL was performed among prenatal care registrants. The diagnosis of gestational diabetes was determined by 100-g, three-hour oral glucose tolerance test (GTT) results and/or repeated fasting serum glucose measures.
RESULTS: In 1995, 69 women were referred to the gestational diabetes clinic with a 50-g result > or = 200 mg/dL. Four women could not be classified, two had pregestational glucose intolerance and four charts were unavailable. Of the remaining 59 women, 11 (19%) had normal three-hour GTTs, and 48 (81%) were diagnosed with gestational diabetes (35 [59%], A1; 13 [22%], A2). There was one large-for-gestational-age (LGA) infant born in the nondiabetic group (9%), 13 LGA infants born in the A1 group (37%) and 6 LGA infants born to the A2 diabetics (46%). The relationship between maternal diagnosis and LGA outcome was statistically significant.
CONCLUSION: A 50-g screening test result > or = 200 mg/dL is not diagnostic of gestational diabetes. Nearly one of five such women had a normal three-hour oral GTT. Overdiagnosis of gestational diabetes may lead to unnecessary pregnancy surveillance and intervention.

Entities:  

Mesh:

Year:  1999        PMID: 10483538

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Pregnancy Outcomes in Women with 1-Hour Glucose Challenge Test ≥ 200 mg/dL.

Authors:  Nana-Ama Ankumah; Alan T N Tita; Joseph R Biggio; Lorie M Harper
Journal:  Am J Perinatol       Date:  2015-11-03       Impact factor: 1.862

2.  Diagnostic ability of elevated 1-h glucose challenge test.

Authors:  L A Temming; M G Tuuli; M J Stout; G A Macones; A G Cahill
Journal:  J Perinatol       Date:  2016-01-21       Impact factor: 2.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.